All Over-The-Counter drug products warehoused recalled over manufacturing violations

Recall date

August 14, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Inmar Supply Chain Solutions, LLC recalls All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

Recall number

D-1104-2023

FDA classification

Class II

Brand / firm

Inmar Supply Chain Solutions, LLC

Sold / distributed

Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.

Why it was recalled

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.